BackLandos Biopharma Overview

Landos Biopharma Total Current Liabilities

Landos Biopharma's total current liabilities is $6.7M.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$6.74M
↑ 62.07% YoYΔ $2.58M vs prior year quarter

Peer trimmed avg / median

Loading

Landos Biopharma Total Current Liabilities History

Loading

Landos Biopharma vs. peers: Total Current Liabilities Comparison

Loading

Landos Biopharma Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Landos Biopharma (LABP) FAQ

Landos Biopharma (LABP) currently reports a total current liabilities of $6.7M as of March 2024. That compares with $4.2M in the prior-year period — up 62.1% year over year. Use the charts on this page to explore Landos Biopharma's total current liabilities history and peer comparisons.

Landos Biopharma's total current liabilities increased from $4.2M to $6.7M — a 62.1% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Landos Biopharma reported $6.7M in total current liabilities as of March 2024. That compares with $4.2M in the prior-year period — up 62.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $6.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Landos Biopharma, and consider following LABP for alerts when major investors trade the stock.

Landos Biopharma is classified in the Healthcare sector. On total current liabilities, it currently shows $6.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LABP with unrelated industries.